Axonal degeneration is a hallmark of numerous neurological diseases, including multiple sclerosis, Alzheimer’s, peripheral neuropathies, and traumatic brain injuries. It involves the progressive breakdown of axons—the communication fibers connecting neurons—leading to irreversible loss of neural function. Understanding the cellular and molecular pathways underlying axonal damage is critical for developing neuroprotective strategies.

The Axonal Degeneration session focuses on mechanisms of axonal injury, cellular responses, and therapeutic targets that can halt or reverse nerve fiber loss. Researchers will explore mitochondrial dynamics, oxidative stress, and immune responses contributing to axonal pathology.

At the Axonal Degeneration Conference, global experts emphasize the need for precision neurotherapeutics, combining molecular biology, imaging, and electrophysiology to identify biomarkers for early detection. New advances in nanomedicine and bioengineered scaffolds are also opening avenues for axonal regeneration and recovery.

Clinicians, neuroscientists, and pharmacologists attending this session will discover novel findings on axonal resilience, degeneration signaling, and axon–glia interactions. The integration of neuroimmunology and regenerative medicine offers exciting prospects for future clinical applications.

Recent breakthroughs in Neural Repair and Regeneration provide additional inspiration, highlighting how damaged neurons can be restored through cellular reprogramming and growth factor therapies.